Revenue Comparison
Chart: Revenue Comparison. Values in USD_BILLIONS. In Q2 2026: Sanofi 13.284, BioNTech 0.114.
Sanofi vs BioNTech Net Worth and Market Cap
Sanofi (SNY) and BioNTech (BNTX) are peers in Vaccines. Sanofi reported revenue of $13.3B as of Q2 2026, compared with $114M for BioNTech. Sanofi leads on revenue.
Sanofi's gross margin is 75.5% versus 8.1% for BioNTech. Sanofi's net margin is 2.8% versus -777.3% for BioNTech.
Latest Quarter Comparison
Table: Latest Quarter Comparison. 15 rows across Metric, Sanofi, BioNTech.| Metric | Sanofi | BioNTech |
|---|---|---|
| Market Cap | - | - |
| Revenue | $13.28B | $114.00M |
| Cost of Revenue | $3.26B | $105.00M |
| Gross Profit | $10.03B | $9.00M |
| Operating Income | $2.58B | $-1.02B |
| Net Income | $370.00M | $-886.00M |
| R&D Expense | $2.41B | $595.00M |
| Earnings Per Share | $0.15 | -$3.5 |
| Gross Margin | 75.5% | 8.1% |
| Operating Margin | 19.4% | -897.8% |
| Net Profit Margin | 2.8% | -777.3% |
| Free Cash Flow | $4.22B | $-48.00M |
| Cumulative Free Cash Flow | $51.81B | $19.56B |
| Operating Cash Flow | $5.85B | $12.00M |
| Cash & Equivalents | $6.86B | $10.52B |
Prefer Sterling in Google
Add sterlingcharts.com as a preferred source so our charts can appear with a preferred badge in Google Top Stories, AI Mode, and AI Overviews.